What if you could lose weight with a drug that won’t make you lose your lunch at the same time? New research shows it might be possible. Scientists at the University of Pennsylvania, the University of Kentucky, and other institutions say they’ve found a potentially novel way to suppress people’s appetite and treat obesity—without causing […]
This Simple Strategy Could Curb One of Semaglutide’s Worst Side Effects
Semaglutide’s ability to help people lose weight is legendary, but so are the side effects. The active ingredient in medications Wegovy and Ozempic, semaglutide is renowned for causing severe nausea in some people, sometimes to the extent that they stop treatment. But new research published in the journal Diabetes Care suggests there may be a […]
Need a Testosterone Boost? Maybe Try Some Ozempic
Is there anything that Ozempic and drugs like it can’t do? A study out today finds that GLP-1 medications often raise men’s testosterone. Scientists in St. Louis, Missouri, led the research, which studied men taking one of several GLP-1 drugs for their type 2 diabetes or obesity. On average, men’s testosterone rose significantly after they started […]
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs
Bad blood is brewing among some major players in the weight loss world. Novo Nordisk, the creator of Ozempic and Wegovy, cut short its partnership with telehealth company Hims & Hers Health Inc. over allegations that the latter is still trying to mass-market cheaper versions of the GLP-1 drugs. Bloomberg News reported the abrupt dissolution […]
People on Ozempic Are Drinking Way Less
Ozempic and similar drugs aren’t just for weight loss, more and more research is finding. New data is the latest to show that GLP-1 medications help lower people’s alcohol consumption, too. Scientists in Ireland and Saudi Arabia conducted the study, which involved around 200 patients who were prescribed GLP-1 drugs to manage their obesity. They […]
Semaglutide Shows Major Promise for Treating Serious Liver Disease
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, is poised to add to its growing list of medical uses. In a large-scale clinical trial published today, semaglutide was found to be effective at treating a severe and relatively common form of liver disease. Researchers in the U.S. and the U.K. led the Phase […]
How Ozempic and Similar Drugs Are Quietly Rewriting America’s Eating Habits
Research out this week might help you plan your own version of the Ozempic diet, with the results of a survey revealing the foods that people tend to avoid, or eat less of, once they start taking GLP-1 drugs. Scientists at the Arkansas Agricultural Experiment Station led the study, a survey of past, current, and […]
Scientists Discover Potential Ozempic Rival That Could Help People Lose Weight With Less Nausea
Wegovy, eat your heart out. In a new research paper, scientists say they’ve discovered a naturally occurring hormone that might help people lose weight while avoiding the side effects commonly associated with semaglutide (the active ingredient in Ozempic and Wegovy) and similar drugs. A team of researchers at Stanford Medicine conducted the study, published last […]
Does Ozempic Really Cause Thyroid Cancer? What the Science Actually Says
For all the buzz surrounding Ozempic and similar GLP-1 drugs for weight loss, there are also plenty of concerns about potential serious or long-term side effects. Among the scariest of these fears is that GLP-1 drugs may cause certain types of thyroid cancer. The risk is relevant enough that the Food and Drug Administration has […]
Eye Doctors Are Finding New Links Between Ozempic and Vision Problems
The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several people who developed eye conditions soon after they began taking semaglutide and similar medications. Eye doctors at the University of Utah Health and elsewhere published the research, which describes several cases of vision complications possibly […]